Stock analysts at HC Wainwright issued their Q3 2025 earnings per share estimates for shares of Intellia Therapeutics in a report issued on Wednesday, March 5th. HC Wainwright analyst M. Kapoor ...
HC Wainwright reissued their buy rating on shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) in a report published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback